Startup Funding Espresso – How To Handle an Exploding Term Sheet
[audio src="https://traffic.libsyn.com/secure/angelconnect/04.how_to_handle_an_exploding_terms_dheet_2.mp3"][/audio]How To Handle an Exploding Term Sheet Hello, this is Hall T. Martin with the Startup Funding Espresso -- your daily shot of startup funding and investing. An exploding term sheet is one that comes with a specific deadline, including a time of day and date. It often gives…
Startup Funding Espresso – Key Factors Impacting Investor Returns
[audio src="https://traffic.libsyn.com/secure/angelconnect/03.key_factors_impacting_investor_returns.mp3"][/audio]Key Factors Impacting Investor Returns Hello, this is Hall T. Martin with the Startup Funding Espresso -- your daily shot of startup funding and investing. Startup investors seeking higher returns should consider the following factors: Due diligence -- there must be a meaningful amount of due diligence performed on…
Startup Funding Espresso – Building a Startup Portfolio
[audio src="https://traffic.libsyn.com/secure/angelconnect/02.building_a_startup_portfolio.mp3"][/audio]Building a Startup Portfolio Hello, this is Hall T. Martin with the Startup Funding Espresso -- your daily shot of startup funding and investing. Startup investing requires a portfolio approach. Here are some best practices for building a startup portfolio. Determine how much time and investment dollars to allocate…
Startup Funding Espresso – What To Include in a Due Diligence Report
[audio src="https://traffic.libsyn.com/secure/angelconnect/01.what_to_include_in_a_due_diligence_report.mp3"][/audio]What To Include in a Due Diligence Report Hello, this is Hall T. Martin with the Startup Funding Espresso -- your daily shot of startup funding and investing. The due diligence report is written by the due diligence team. It covers the financial, operational, legal, and strategic aspects of…
Investor Connect: JIP Strategy, Licensing, and Deal Readiness in Life Sciences
On this episode of Investor Connect, Hall Marchant welcomes Gillian Fenton of LST Strategies, who brings more than 30 years of experience in licensing intellectual property and life sciences transactions, including work with GSK, Emergent BioSolutions, and Biogen, as well as university startups, established life science companies, and investors. Gillian…
